PER

5.26%

8.0¢ percheron therapeutics limited

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-240

First 240 Last

Share
Profile

Follow
arjay

3,565 Posts.

772

21/07/21

11:36

Post #: 54655919
Share

Originally posted by samfiodiving ↑

I sometimes wonder what sort of investors we have on board when you look at the TU people receive

What sort of DD are some people carrying out on their investment, perhaps they just visit HC and believe all the sunshine and roses that get posted here

For instance you get Gassy coming out with this statement

in 18 months the DMD trial will be over ....I reckon that Imo the trial will not go the full 12 months because of the urgency...
So I think by end of 2022 we will be selling Atl1102 for DMD in Europe and USA... even Australia....
Dmd market will be $4 billion

What a ridiculous statement Gassy i just could not believe what i was reading and the thing is this post got 14thumbs up and 3 great Analysis WHAT LOL

Then we get anp2dollars that comes out with a fact but puts it in a nice way as in

Wouldn't it be fairly unusual to have an early readout on a double-blinded, placebo-controlled trial? I know we got early results on our IIA because that was an open label trial. Correct me if I'm wrong but I doubt we get any early reads on the next trial.

Spot on ANP2 you are correct as far as we know, this is going to be a double blind placebo so there is no way this trial will be finished earlier than expected.

As for selling product by the end of 2022 again laughable we will be lucky if all results come to market by the end of 2023

But once again this is IMHO just like gassy,s

I think the presso today is highlighting a Massive Cr coming and once more IMHO explains the constant selling into in the mid 20s

Why would you sell now, you wouldn't unless you were expecting to have a huge top up at some stage

I could well be wrong and happy to admit it if i am, unlike some here

The Preso looked good obviously $$$ been spent

Question is WHO is it directed towards ( Obviously not a pharma )

Time will tell it always does

SEE HOW WE GO

Expand

For some reason ...I think this play is more than just CR..

Look at the shares that were traded yesterday...

Even if it's a CR...I think it will be with some bonus announcements..

Looks very strange...You saying sell off but Vol had been low ...

I could be wrong ....

Let's see how we go...lol

ANP Price at posting: 19.3¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Emerald & Azure score Digger & Dealer awards

TNC

True North increases silver metal at QLD's Vero deposit by 20%

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

There are more pages in this discussion • 48 more messages in this thread...

First 240 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change 0.004(5.26%)		Mkt cap ! $72.12M

Open	High	Low	Value	Volume
7.9¢	8.0¢	7.7¢	$35.48K	451.2K

Buyers (Bids)

No.	Vol.	Price($)
1	12500	7.8¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	198147	2

View Market Depth

No.	Vol.	Price($)
1	1471	0.077
1	69866	0.074
1	75000	0.073
2	15000	0.070
1	100000	0.067

Price($)	Vol.	No.
0.080	198147	2
0.081	198015	2
0.082	75174	2
0.083	93000	1
0.084	200300	2

Last trade - 16.10pm 09/08/2024 (20 minute delay)

PER (ASX) Chart

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-240

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Emerald & Azure score Digger & Dealer awards

True North increases silver metal at QLD's Vero deposit by 20%

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-240

Top Stories

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Revolutionary inverter technology leads the clean energy charge

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Emerald & Azure score Digger & Dealer awards

True North increases silver metal at QLD's Vero deposit by 20%

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News